Researchers in Japan find that tapering or reducing benzodiazepines has a positive effect on quality of life, verbal and working memory, and psychiatric symptoms in people with a schizophrenia diagnosis, with no adverse effects. The study found that a daily dose reduction strategy of 25-50% per 2-4 weeks was safe. The study appears in the upcoming issue of Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Read more Discuss →
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
***
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.